Condition
Pain, Face
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04948541Not ApplicableCompleted
Effect Of Sleep Apnea Treatment On Temporo-Mandibular Disorders
NCT03894553Not ApplicableCompleted
Focused Ultrasound (FUS) Mesencephalotomy for Head & Neck Cancer Pain
NCT06955650Early Phase 1CompletedPrimary
First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors
NCT04831346Not ApplicableRecruiting
Effects of Low-Level Laser Therapy on Mouth Opening and Surface Electromyography in Temporomandibular Disorders
NCT03456154Phase 4CompletedPrimary
Botox vs Occlusal Splint for Masseter Pain
Showing all 5 trials